Amzeeq (Minocycline HCl) Patent Expiration, LOE Window & CMS Spending

Amzeeq (Minocycline HCl) by Journey Medical: FDA Orange Book LOE 2037-09-08, 16 AB generics, $368K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorJourney Medical
FDA Application & PathwayN212379 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2037-09-08
Orange Book Patents (*PED Extensions)12 patents (0 *PED)
Active AB-Rated Generic Competitors16
2024 CMS Total Public Spend$368K
2024 Medicare Part D Spend$368K
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel